BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21767877)

  • 1. A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report.
    Gozzetti A; Cerase A; Crupi R; Raspadori D; Defina M; Bocchia M; Lauria F
    Leuk Res; 2011 Nov; 35(11):e206-8. PubMed ID: 21767877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Close correlations between CD20 expression, a small mature plasma cell morphology and t(11 ; 14) in multiple myeloma].
    Matsuda I; Mori Y; Nakagawa Y; Sawanobori M; Uemura N; Suzuki K
    Rinsho Ketsueki; 2005 Dec; 46(12):1293-7. PubMed ID: 16447802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mott cells in CD20-positive myeloma.
    Ramasamy K; Ladon D; Salisbury J; Ireland R
    Br J Haematol; 2011 Feb; 152(4):366. PubMed ID: 21265822
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
    Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
    Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14).
    Feyler S; O'Connor SJ; Rawstron AC; Subash C; Ross FM; Pratt G; Drayson MT; Ashcroft J; Cook G; Owen RG
    Br J Haematol; 2008 Mar; 140(5):547-51. PubMed ID: 18275432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14).
    Hundemer M; Klein U; Hose D; Raab MS; Cremer FW; Jauch A; Benner A; Heiss C; Moos M; Ho AD; Goldschmidt H
    Bone Marrow Transplant; 2007 Dec; 40(11):1033-7. PubMed ID: 17891186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
    Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
    Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.
    Narita T; Inagaki A; Kobayashi T; Kuroda Y; Fukushima T; Nezu M; Fuchida S; Sakai H; Sekiguchi N; Sugiura I; Maeda Y; Takamatsu H; Tsukamoto N; Maruyama D; Kubota Y; Kojima M; Sunami K; Ono T; Ri M; Tobinai K; Iida S
    Blood Cancer J; 2015 Feb; 5(2):e285. PubMed ID: 25723856
    [No Abstract]   [Full Text] [Related]  

  • 11. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome.
    Vekemans MC; Lemmens H; Delforge M; Doyen C; Pierre P; Demuynck H; Bries G; Lemmens J; Meeus P; Straetmans N; Bauwens D; Vidrequin S; Rack K; Vandenberghe P; Wlodarska I; Michaux L
    Br J Haematol; 2010 Jun; 149(6):901-4. PubMed ID: 20148877
    [No Abstract]   [Full Text] [Related]  

  • 14. A der(22)t(9;22)(p13;q11) in bone marrow cells of a patient with multiple myeloma: a variant of the t(9;14)(p13;q32) associated with a subset of lymphoplasmacytoid lymphoma.
    Smadja NV; Grange MJ
    Cancer Genet Cytogenet; 1998 May; 103(1):78-80. PubMed ID: 9595053
    [No Abstract]   [Full Text] [Related]  

  • 15. CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity.
    Bataille R; Robillard N; Avet-Loiseau H; Harousseau JL; Moreau P
    Haematologica; 2005 May; 90(5):706-7. PubMed ID: 15921396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplastic plasma cells mimic mature neutrophils in plasma cell myeloma with t(11;14)(q13;q32).
    Wang W; Hu S
    Blood; 2015 Apr; 125(18):2875. PubMed ID: 26120642
    [No Abstract]   [Full Text] [Related]  

  • 17. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
    Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
    Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome.
    An G; Xu Y; Shi L; Zou D; Deng S; Sui W; Xie Z; Hao M; Chang H; Qiu L
    Leuk Res; 2013 Oct; 37(10):1251-7. PubMed ID: 23927993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation (11;14)(q13;q32) and partial trisomy 1q in a case of multiple myeloma.
    Kwong YL; Lie AK; Chan LC
    Am J Hematol; 1993 Nov; 44(3):212-3. PubMed ID: 8213777
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
    Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
    Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.